Key regions: Canada, United Kingdom, United States, China, Europe
The Cold & Cough Remedies (Pharmacies) market in Central Asia has been experiencing steady growth in recent years. Customer preferences in the region show a strong demand for over-the-counter cold and cough remedies. This can be attributed to several factors. Firstly, the Central Asian population is becoming increasingly aware of the importance of maintaining good health and preventing illnesses. As a result, there is a growing demand for products that can help alleviate cold and cough symptoms, allowing individuals to continue their daily activities without interruption. Additionally, the convenience and accessibility of purchasing these remedies from local pharmacies contribute to their popularity among customers. Trends in the market indicate a shift towards natural and herbal remedies. Customers are becoming more conscious of the potential side effects associated with traditional pharmaceutical products and are seeking alternative options. This trend is driven by a desire for more holistic and sustainable approaches to healthcare. As a result, there has been an increase in the availability and variety of natural cold and cough remedies in Central Asian pharmacies. Local special circumstances in Central Asia also play a role in the development of the Cold & Cough Remedies market. The region experiences harsh winters, with cold and flu season being particularly prevalent. This creates a high demand for effective remedies to combat these common illnesses. Additionally, the relatively low access to healthcare facilities in some areas of Central Asia means that pharmacies often serve as the primary point of contact for individuals seeking medical advice and treatment. This further drives the demand for cold and cough remedies in pharmacies. Underlying macroeconomic factors contribute to the growth of the Cold & Cough Remedies market in Central Asia. Economic development in the region has led to an increase in disposable income, allowing individuals to spend more on healthcare products. The growing middle class in Central Asia has a higher purchasing power and is willing to invest in their health and well-being. Furthermore, the expanding pharmaceutical industry in the region has resulted in a wider range of cold and cough remedies being available to consumers, catering to their diverse needs and preferences. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Central Asia is developing due to customer preferences for over-the-counter remedies, a trend towards natural and herbal products, local special circumstances such as harsh winters and limited access to healthcare facilities, and underlying macroeconomic factors such as economic development and an expanding pharmaceutical industry.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
